Abstract
High-frame-rate (HFR) echo-particle image velocimetry (echoPIV) is a promising tool for measuring intracardiac blood flow dynamics. In this study, we investigate the optimal ultrasound contrast agent (UCA: SonoVue) infusion rate and acoustic output to use for HFR echoPIV (PRF = 4900 Hz) in the left ventricle (LV) of patients. Three infusion rates (0.3, 0.6, and 1.2 ml/min) and five acoustic output amplitudes (by varying transmit voltage: 5, 10, 15, 20, and 30 V - corresponding to mechanical indices of 0.01, 0.02, 0.03, 0.04, and 0.06 at 60-mm depth) were tested in 20 patients admitted for symptoms of heart failure. We assess the accuracy of HFR echoPIV against pulsed-wave Doppler acquisitions obtained for mitral inflow and aortic outflow. In terms of image quality, the 1.2-ml/min infusion rate provided the highest contrast-to-background ratio (CBR) (3-dB improvement over 0.3 ml/min). The highest acoustic output tested resulted in the lowest CBR. Increased acoustic output also resulted in increased microbubble disruption. For the echoPIV results, the 1.2-ml/min infusion rate provided the best vector quality and accuracy; mid-range acoustic outputs (corresponding to 15-20-V transmit voltages) provided the best agreement with the pulsed-wave Doppler. Overall, the highest infusion rate (1.2 ml/min) and mid-range acoustic output amplitudes provided the best image quality and echoPIV results.
Original language | English |
---|---|
Article number | 9378576 |
Pages (from-to) | 2432-2443 |
Number of pages | 12 |
Journal | IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control |
Volume | 68 |
Issue number | 7 |
Early online date | 15 Mar 2021 |
DOIs | |
Publication status | Published - Jul 2021 |
Bibliographical note
Funding Information:Manuscript received November 27, 2020; accepted March 8, 2021. Date of publication March 15, 2021; date of current version June 29, 2021. This work was supported in part by ZonMw within the Innovative Medical Devices Initiative Program under the Project “Heart Failure and 4-D Flow”; and in part by the project “Ultrafast Ultrasound Imaging for Extended Diagnosis and Treatment of Vascular Disease (ULTRA-X-TREME)” with project number (P17-32) of the research programme “Perspectief” which is (partly) financed by the Dutch Research Council (NWO). (Corresponding author: Jason Voorneveld.) Jason Voorneveld and Johan G. Bosch are with the Department of Biomedical Engineering, Erasmus University Medical Center, 3015 GD Rotterdam, The Netherlands (e-mail: j.voorneveld. . asmusmc.nl).
Publisher Copyright:
© 1986-2012 IEEE.